Synovial fibroblasts in joint destruction of rheumatoid arthritis

Drug Discovery Today: Disease Mechanisms

Volumn 2, Issue 3, 2005, Pages 359-365

  Seemayer, Christian A ^a,b   Neidhart, Michel ^a   Jüngel, Astrid ^a   Gay, Renate E ^a   Gay, Steffen ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CARTILAGE; CELL ACTIVATION; CELL ADHESION; CELL TYPE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE COURSE; FIBROBLAST; HUMAN; HYPERPLASIA; IMMUNE RESPONSE; INFLAMMATION; JOINT DESTRUCTION; PATHOGENESIS; PHENOTYPE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 33645086123     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2005.08.009     Document Type: Review

References (74)

1. S. Gay et. al. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction? Ann. Rheum. Dis. 52 Suppl. 1 1993 S39-S47
2. S. Gay et. al. Cartilage destruction in rheumatoid arthritis Ann. Rheum. Dis. 61 Suppl. 2 2002 ii87
3. C. Ospelt et. al. Synovial activation in rheumatoid arthritis Front. Biosci. 9 2004 2323-2334
4. M.K. Soderlin et. al. Quality of life and economic burden of illness in very early arthritis. A population based study in southern Sweden J. Rheumatol. 31 2004 1717-1722
5. M. Herrmann et. al. Retrovirus-associated rheumatic syndromes Curr. Opin. Rheumatol. 10 1998 347-354
6. C.A. Seemayer et. al. Absence of inducible retroviruses from synovial fibroblasts and synovial fluid cells of patients with rheumatoid arthritis Arthritis Rheum. 46 2002 2811-2813
7. M. Leirisalo-Repo Early arthritis and infection Curr. Opin. Rheumatol. 17 2005 433-439
8. E.M. Gravallese Bone destruction in arthritis Ann. Rheum. Dis. 61 Suppl. 2 2002 ii84-ii86
9. S.T. du Montcel et. al. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility Arthritis Rheum. 52 2005 1063-1068
10. A.J. Svendsen et. al. Relative importance of genetic effects in rheumatoid arthritis: Historical cohort study of Danish nationwide twin population Br. Med. J. 324 2002 264-266
11. U. Muller-Ladner et. al. Cellular pathways of joint destruction Curr. Opin. Rheumatol. 9 1997 213-220
12. H.G. Fassbender et. al. Pathways of destruction in metacarpal and metatarsal joints of patients with rheumatoid arthritis Scand. J. Rheumatol. 21 1992 10-16
13. T.C. Tolboom et. al. Invasive properties of fibroblast-like synoviocytes: Correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10 Ann. Rheum. Dis. 61 2002 975-980
14. Y. Nakamachi et. al. Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts Arthritis Rheum. 48 2003 668-674
15. P.F. Bradfield et. al. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue Arthritis Rheum. 48 2003 2472-2482
16. U. Muller-Ladner et. al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice Am. J. Pathol. 149 1996 1607-1615
17. M. Pierer et. al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands J. Immunol. 172 2004 1256-1265
18. G.S. Firestein et. al. Apoptosis in rheumatoid arthritis: P53 overexpression in rheumatoid arthritis synovium Am. J. Pathol. 149 1996 2143-2151
19. F. Kullmann et. al. Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts Arthritis Rheum. 42 1999 1594-1600
20. C.A. Seemayer et. al. p53 in rheumatoid arthritis synovial fibroblasts at sites of invasion Ann. Rheum. Dis. 62 2003 1139-1144
21. P. Kuenzler et. al. Induction of p16 at sites of cartilage invasion in the SCID mouse coimplantation model of rheumatoid arthritis Arthritis Rheum. 48 2003 2069-2073
22. C.A. Seemayer et. al. Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis Am. J. Pathol. 162 2003 1549-1557
23. R. Lafyatis et. al. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids J. Clin. Invest. 83 1989 1267-1276
24. T. Pap et. al. Activation of synovial fibroblasts in rheumatoid arthritis: Lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction Arthritis Res. 2 2000 59-64
25. Y.T. Konttinen et. al. DNA synthesis in prolyl 4-hydroxylase positive fibroblasts in situ in synovial tissue. An autoradiography-immunoperoxidase double labeling study J. Rheumatol. 16 1989 339-345
26. M. Sugiyama et. al. Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis Ann. Rheum. Dis. 55 1996 442-449
27. Z. Qu et. al. Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining Arthritis Rheum. 37 1994 212-220
28. S. Yamasaki et. al. Importance of NF-kappaB in rheumatoid synovial tissues: In situ NF-kappaB expression and in vitro study using cultured synovial cells Ann. Rheum. Dis. 60 2001 678-684
29. G.S. Firestein et. al. Apoptosis in rheumatoid arthritis synovium J. Clin. Invest. 96 1995 1631-1638
30. T. Nakajima et. al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes Arthritis Rheum. 38 1995 485-491
31. C.T. Chou et. al. Apoptosis in rheumatoid arthritis - expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues J. Pathol. 193 2001 110-116
32. H. Asahara et. al. In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium J. Rheumatol. 24 1997 430-435
33. K. Okamoto et. al. Fas-associated death domain protein is a Fas-mediated apoptosis modulator in synoviocytes Rheumatology (Oxford) 39 2000 471-480
34. J. Highton et. al. Cell death by apoptosis is a feature of the rheumatoid nodule Ann. Rheum. Dis. 62 2003 77-80
35. J.K. Franz et. al. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis Arthritis Rheum. 43 2000 599-607
36. J.D. Mountz H.G. Zhang Regulation of apoptosis of synovial fibroblasts Curr. Dir. Autoimmun. 3 2001 216-239
37. H. Perlman et. al. Regulation of apoptosis and cell cycle activity in rheumatoid arthritis Curr. Mol. Med. 1 2001 597-608
38. J. Schedel et. al. FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis Arthritis Rheum. 46 2002 1512-1518
39. T. Kobayashi et. al. Differential regulation of Fas-mediated apoptosis of rheumatoid synoviocytes by tumor necrosis factor alpha and basic fibroblast growth factor is associated with the expression of apoptosis-related molecules Arthritis Rheum. 43 2000 1106-1114
40. S. Ohshima et. al. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: A possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA Cytokine 12 2000 281-288
41. Y.W. Park et. al. Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis Scand. J. Rheumatol. 32 2003 356-363
42. M. Neidhart et. al. Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: Association with genomic DNA hypomethylation and influence on gene expression Arthritis Rheum. 43 2000 2634-2647
43. S. Kuchen et. al. The L1 retroelement-related p40 protein induces p38delta MAP kinase Autoimmunity 37 2004 57-65
44. J.K. Franz et. al. Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis Eur. J. Immunol. 28 1998 2661-2671
45. C. Ospelt et. al. Toll-like receptors in rheumatoid arthritis joint destruction mediated by two distinct pathways Ann. Rheum. Dis. 63 Suppl. 2 2004 ii90-ii91
46. F. Brentano et. al. The role of Toll-like receptor signalling in the pathogenesis of arthritis Cell Immunol. 233 2005 90-96
47. M. Neidhart et. al. Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein Ann. Rheum. Dis. 64 2005 419-424
48. M. Neidhart et. al. Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: Destructive potential in vitro and in vivo Arthritis Rheum. 48 2003 1873-1880
49. E.A. Jones et. al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis Arthritis Rheum. 50 2004 817-827
50. J.A. Stebulis et. al. Fibroblast-like synovial cells derived from synovial fluid J. Rheumatol. 32 2005 301-306
51. N. Rinaldi et. al. Differential expression and functional behaviour of the alpha v and beta 3 integrin subunits in cytokine stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro Ann. Rheum. Dis. 56 1997 729-736
52. U. Muller-Ladner et. al. Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium J. Rheumatol. 24 1997 1873-1880
53. M. Neidhart et. al. Anti-interleukin-1 and anti-CD44 interventions producing significant inhibition of cartilage destruction in an in vitro model of cartilage invasion by rheumatoid arthritis synovial fibroblasts Arthritis Rheum. 43 2000 1719-1728
54. S. Hayer et. al. CD44 is a determinant of inflammatory bone loss J. Exp. Med. 201 2005 903-914
55. S. Ohshima et. al. Galectin 3 and its binding protein in rheumatoid arthritis Arthritis Rheum. 48 2003 2788-2795
56. J.H. Distler et. al. Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis Arthritis Rheum. 50 2004 10-23
57. D. Wernicke et. al. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice Arthritis Rheum. 46 2002 64-74
58. Y. Ma R.M. Pope The role of macrophages in rheumatoid arthritis Curr. Pharm. Des. 11 2005 569-580
59. Y.T. Konttinen et. al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: Different profiles in trauma and rheumatoid arthritis Ann. Rheum. Dis. 58 1999 691-697
60. G. Cunnane et. al. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis Rheumatology (Oxford) 38 1999 34-42
61. T. Pap et. al. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis Arthritis Rheum. 43 2000 1226-1232
62. E. Rutkauskaite et. al. Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts Arthritis Rheum. 50 2004 1448-1456
63. E. Rutkauskaite et. al. Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts Arthritis Rheum. 52 2005 2010-2014
64. Yuan, J. et al. RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion. J. Orthop. Res. (in press)
65. G.S. Firestein M.M. Paine Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium Am. J. Pathol. 140 1992 1309-1314
66. G. Cunnane et. al. Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis Arthritis Rheum. 44 2001 2263-2274
67. W.H. van der Laan et. al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3 Gene Ther. 10 2003 234-242
68. K.M. Hummel et. al. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction J. Rheumatol. 25 1998 1887-1894
69. Y. Shigeyama et. al. Expression of osteoclast differentiation factor in rheumatoid arthritis Arthritis Rheum. 43 2000 2523-2530
70. J. Schedel et. al. Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis Gene Ther. 11 2004 1040-1047
71. U. Muller-Ladner et. al. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective J. Immunol. 158 1997 3492-3498
72. U. Muller-Ladner et. al. Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model Arthritis Rheum. 42 1999 490-497
73. E. Neumann et. al. Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway Gene Ther. 9 2002 1508-1519
74. T.C. Tolboom et. al. Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis Arthritis Rheum. 52 2005 1999-2002